Target intelligence / Profile preview

Hemoglobin subunit zeta pseudogene 1 (HBZP1)

Target: HBZP1
Molecular classification: Other (pseudogene)

Overview

Hemoglobin subunit zeta pseudogene 1 (HBZP1) is classified as a pseudogene, specifically an unprocessed pseudogene within the human alpha-globin gene cluster on chromosome 16[5][7]. Unlike the functional hemoglobin subunit zeta gene (HBZ), HBZP1 does not encode a functional protein and is not known to play a direct biological or therapeutic role[5][7]. It is not a recognized therapeutic target, and there are no established functions, disease associations, drug interactions, or biomarker roles attributed to this pseudogene.

Other names: HBZ-T2HBZ2HBZ2PHBZPhemoglobin, zeta pseudogene 1zeta globin pseudogene

Beyond the preview

Go deeper on Hemoglobin subunit zeta pseudogene 1 (HBZP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemoglobin subunit zeta pseudogene 1 (HBZP1).

Explore the full profile